NURS FPX 9020 Assessment 1: Project Implementation in Practice

Introduction

The Doctor of Nursing Practice (DNP) project implementation phase involves applying evidence-based results to improve clinical issues. This paper details the perpetration process of a nanny-led digital hypertension operation program designed to enhance drug adherence and blood pressure control in grown-ups with habitual hypertension. The discussion covers design objects, perpetration procedures, outgrowth measures, challenges, and assignments learned from the perpetration phase. 

NURS FPX 9020 Assessment 1:Overview and Purpose

The DNP design aimed to ameliorate drug adherence and hypertension control among adult cases through a digital adherence intervention combining nanny coaching, mobile monuments, and patient education. 

Objectives:

1. Increase drug adherence scores by 25 over 12 weeks. 
2. Ameliorate means systolic blood pressure (SBP) by at least 10 mmHg. 
3. Strengthen nanny-case communication and digital engagement. 

This design aligns with Healthy People 2030 pretensions of reducing hypertension-related morbidity through better treatment adherence (U.S. Department of Health and Human Services (HHS), 2021). 

Implementation Setting and Participants

The design was enforced in a primary care clinic serving roughly 2,500 adult cases. 

Actors included 30 grown-ups aged 30–70 times diagnosed with hypertension, taking at least one antihypertensive drug, and retaining a smartphone compatible with the mobile adherence app. 

Inclusion Criteria

• Diagnosed hypertension (≥ 140/90 mmHg) 
• specified drug for at least six months 
• Access to digital technology 

Exclusion Criteria

• Cognitive impairments 
• incapability to concurrence 
• Participation in other adherence studies 

Implementation Procedures

Phase 1: Preparation (Weeks 1–2)

• attained Institutional Review Board (IRB) blessing. 
• Conducted nanny training on digital adherence tools. 
• Configured mobile memorial systems and EHR integration. 
• Developed educational accoutrements on drug adherence. 

Phase 2: Recruitment and Baseline Data Collection (Weeks 3–4)

• signed 30 actors via clinic referrals. 
• attained informed concurrence. 
• Recorded birth BP readings and MMAS-8 (Morisky Medication Adherence Scale) scores. 

Phase 3: Intervention (Weeks 5–12)

• Actors entered personalized nanny guiding sessions and app setup backing. 
• Nurses conducted daily telehealth follow-ups to address falls. 
• Mobile monuments transferred daily drug cautions. 

Phase 4: Post-Implementation Evaluation (Weeks 13–14)

• Collected follow-up BP readings and MMAS-8 scores. 
• Conducted semi-structured interviews to capture party guests. 

Evaluation of Outcomes

Quantitative Results

After 12 weeks 

• Drug adherence was better by a normal of 30, with MMAS-8 scores rising from 5.2 to 7.1 (p < 0.05). 
• Systolic blood pressure dropped from a mean of 146 mmHg to 134 mmHg. 
• Diastolic blood pressure improved modestly from 90 to 84 mmHg. 

Qualitative Results

Three main themes surfaced. 

1. commission through technology – Cases felt in control of their health. 
2. Nanny-case cooperation—nonstop engagement bettered responsibility. 
3. Ease of digital integration – App monuments reduced obliviousness. 

Challenges and Barriers

Technology Literacy

Some actors plodded originally with app setup, taking extended nanny backing. 

Engagement Decline

Engagement slightly dropped in the final two weeks, pressing the need for sustained provocation strategies. 

Workflow Integration

Nurses reported time constraints during case follow-up calls; future integration into EHR workflow robotization is recommended. 

Ethical and Legal Considerations

• Informed concurrence was attained before participation. 
• Confidentiality was maintained through de-identified data storehouses. 
• Voluntary participation was emphasized. 
• Data security complied with HIPAA regulations.

Sustainability and Dissemination Plan

Sustainability

1. Incorporate the mobile adherence app into the clinic’s habitual complaint operation program. 
2. Train nursing staff for ongoing use beyond design completion. 
3. Examiner adherence criteria daily as part of quality enhancement (QI) enterprise. 

Dissemination

• donation to clinic leadership and quality enhancement commission. 
• Submission to The Journal of Nursing Care Quality for publication. 
• Bill donation at the American Association of Nurse Interpreters (AANP) Conference. 

Conclusion

The DNP design successfully demonstrated that nanny-led digital adherence programs can significantly ameliorate drug adherence and blood pressure control. The combination of nursing engagement, digital monuments, and patient education produced measurable advancements and positive feedback. Unborn enterprises should concentrate on spanning this model to other habitual complaint populations similar to diabetes and heart failure.